108 related articles for article (PubMed ID: 12081325)
21. [FTIR spectroscopic characterization of freshly removed breast cancer tissues].
Zhou S; Xu Z; Ling XF; Li QB; Xu YZ; Zhang L; Zhao HM; Wang LX; Hou KY; Zhou XS; Wu JG
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):512-4. PubMed ID: 17147115
[TBL] [Abstract][Full Text] [Related]
22. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.
O'Connell JT; Shao ZM; Drori E; Basbaum CB; Barsky SH
Hum Pathol; 1998 Dec; 29(12):1517-23. PubMed ID: 9865841
[TBL] [Abstract][Full Text] [Related]
23. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
Soriano Z; Pardee JD
Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
[TBL] [Abstract][Full Text] [Related]
24. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma.
Stanley MJ; Stanley MW; Sanderson RD; Zera R
Am J Clin Pathol; 1999 Sep; 112(3):377-83. PubMed ID: 10478144
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
Demir H; Turna H; Can G; Ilvan S
J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
[TBL] [Abstract][Full Text] [Related]
26. Invasive ductal carcinoma, fibroadenoma and adjacent breast stroma angiogenesis: an immunohistochemical and morphometrical study.
Da Silva ID; De Lima GR; Gebrim LH; Baracat FF; Focchi GR; Evncio Neto J; Simões MJ
Bull Assoc Anat (Nancy); 1996 Sep; 80(250):17-9. PubMed ID: 9127689
[TBL] [Abstract][Full Text] [Related]
27. [Expression of CERS2 in invasive breast cancer tissues and its clinical significance].
Wang YY; Gao LY; Zhao YH; Li JY; Luo Q; Fan SH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):267-8. PubMed ID: 23928536
[No Abstract] [Full Text] [Related]
28. Comments on p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Rudas et al., Eur. J. Cancer 1997, 33, No. 1, 39-44.
Schmitt FC
Eur J Cancer; 1997 Oct; 33(11):1903-4. PubMed ID: 9470856
[No Abstract] [Full Text] [Related]
29. Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease.
Li X; Huang W; Yankeelov TE; Tudorica A; Rooney WD; Springer CS
Magn Reson Med; 2005 Mar; 53(3):724-9. PubMed ID: 15723402
[TBL] [Abstract][Full Text] [Related]
30. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
Berclaz G; Altermatt HJ; Rohrbach V; Siragusa A; Dreher E; Smith PD
Int J Oncol; 2001 Dec; 19(6):1155-60. PubMed ID: 11713584
[TBL] [Abstract][Full Text] [Related]
31. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue.
Gribbestad IS; Fjösne HE; Haugen OA; Nilsen G; Krane J; Petersen SB; Kvinnsland S
Anticancer Res; 1993; 13(6A):1973-80. PubMed ID: 8297103
[TBL] [Abstract][Full Text] [Related]
32. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic potential of Stokes Shift spectroscopy of breast and prostate tissues-- a preliminary pilot study.
Ebenezar J; Pu Y; Liu CH; Wang WB; Alfano RR
Technol Cancer Res Treat; 2011 Apr; 10(2):153-61. PubMed ID: 21381793
[TBL] [Abstract][Full Text] [Related]
34. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.
Kostova NN; Srebreva LN; Milev AD; Bogdanova OG; Rundquist I; Lindner HH; Markov DV
Histochem Cell Biol; 2005 Nov; 124(5):435-43. PubMed ID: 16158288
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
Pilichowska M; Kimura N; Fujiwara H; Nagura H
Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
[TBL] [Abstract][Full Text] [Related]
37. Studies on certain cytoplasmic enzymes and specific estrogen receptors in human breast cancer and in nonmalignant diseases of the breast.
Hilf R; Wittliff JL; Rector WD; Savlov ED; Hall TC; Orlando RA
Cancer Res; 1973 Sep; 33(9):2054-62. PubMed ID: 4353478
[No Abstract] [Full Text] [Related]
38. Immunohistochemical studies of S-100 protein expression in myoepithelial cells of benign breast diseases and normal breast tissues.
Umekita Y; Fujiyoshi T; Takasaki T; Kuriwaki K; Yoshida A; Yoshida H
In Vivo; 1993; 7(5):415-8. PubMed ID: 8110983
[TBL] [Abstract][Full Text] [Related]
39. [The cytospectrophotometric study of the DNA content in benign and malignant processes in the breast].
Borodaĭ NV
Tsitol Genet; 1999; 33(3):27-33. PubMed ID: 10474860
[TBL] [Abstract][Full Text] [Related]
40. Increased oxidative damage to membrane lipids following surgery for breast cancer.
Szychta P; Zadrozny M; Lewinski A; Karbownik-Lewinska M
Neuro Endocrinol Lett; 2014; 35(7):602-7. PubMed ID: 25617883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
